Médecins Sans Frontières told PACCARB that 90% of AMR deaths occur in low- and middle-income countries and asked the U.S. to retain and expand technical, financial and political support for globally relevant microbiome and AMR interventions.

On April 1 the House passed HB 18 55 (add alpha‑gal syndrome to reportable conditions), HB 23 55 (MoHealthNet Food as Medicine waiver authority) and HB 31 13 (require naloxone availability in public buildings). Sponsors said the bills address public-health surveillance, nutrition-based interventions for Medicaid participants and overdose preparedness.